PTN News

  • Duke kicks off sixth annual STAR Program for aspiring researchers June 19, 2018 Duke’s Summer Training in Academic Research (STAR) Program welcomed twenty one participants at its kickoff event today. Now in its sixth year, the program provides hands-on research experience for undergraduate students, high school students, and high school teachers during the summer academic break. “The STAR program is an excellent way for students to learn more about clinical ...
  • PTN creates data repository to aid in pediatric research May 7, 2018 Randomized clinical trials are considered the gold standard in clinical research. However, they often require a great deal of time and cost, and may not be feasible to conduct in vulnerable populations such as premature infants. To overcome these difficulties, the Pediatric Trials Network (PTN) developed a repository of electronic health record (EHR) data gathered from ...
  • PTN to present at PAS 2018 Meeting in Toronto April 18, 2018 The Pediatric Trials Network (PTN) will be presenting its research at the Pediatric Academic Societies (PAS) Meeting May 5-8 at the Metro Toronto Convention Centre in Toronto, Canada. The annual PAS Meeting brings together thousands of researchers, academics, and clinical care providers united by a common mission: to improve the health and well-being of children worldwide. ...
  • PTN welcomes first sites in Australia March 27, 2018 The Pediatric Trials Network (PTN) welcomed its first two Australian sites in February. Sydney Children’s Hospitals Network and the Royal Children’s Hospital in Melbourne are now participating in PTN’s Pharmacokinetics of Understudied Drugs in Infants and Children (POPS) study. The sites are currently involved in the Paediatric Trials Network Australia (PTNA), a counterpart of PTN that ...
  • Groundbreaking study to assess safety of drugs passed through breastmilk February 13, 2018 The Pediatric Trials Network (PTN) is undertaking a groundbreaking study to assess the safety of commonly used off-patent medications when they are given to breastfeeding mothers. The study will track how different drugs are passed through breastmilk to determine dosing levels that are safe for both mom and baby. Although the U.S. Food and Drug Administration ...
  • 15 IDeA sites welcomed into PTN POPS study February 6, 2018 Fifteen sites in states participating in the NIH Institutional Development Award (IDeA) program are being onboarded into the Pediatric Trials Network’s (PTN) POPS study of commonly used medications in children. The IDeA program aims to build research capacities in states that have historically received low levels of NIH funding by supporting research, faculty development, and infrastructure ...
  • Dr. Shakhnovich offers guidelines for prescribing GERD medications to obese kids February 1, 2018   When treating gastroesophageal reflux disease (GERD) in obese kids, the common practice of dosing stomach acid blockers based on children’s weight could actually cause more harm than good, said Dr. Valentina Shakhnovich, investigator for the Pediatric Trials Network (PTN) and Associate Program Director for the Gastroenterology Fellowship Research Program at Children’s Mercy Hospitals in Kansas ...
  • Sildenafil safety studied for premature infants with bronchopulmonary dysplasia January 18, 2018 The Pediatric Trials Network (PTN), with support from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, is conducting an interventional study to examine the safety and efficacy of sildenafil in treating bronchopulmonary dysplasia (BPD) in premature infants. BPD is a common chronic lung disease that can affect premature newborns, often leading to ...
  • PTN captures valuable anthropometric data for infants January 8, 2018 The Pediatric Trials Network (PTN) conducted a study in 2015 to capture anthropometric data on pre-term and full-term infants up to 90 days old. An article on the study, An Anthropometric Survey of U.S. Preterm and Full-Term Neonates, was published in the journal Annals of Human Biology last month. “Anthropometric data are invaluable for informing the ...
  • PTN investigator to retire at end of 2017 November 17, 2017   In 2004, Dr. Ram Yogev, Director of the Section on Pediatric, Adolescent and Maternal HIV Infection at the Ann & Robert H. Lurie Children’s Hospital of Chicago, was invited to serve on an FDA advisory committee on anti-retroviral, anti-fungal and anti-tuberculosis drugs. As the only pediatrician on the committee, he was surprised to see that ...